X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
to6 (41) 41
humans (38) 38
index medicus (38) 38
oncology (38) 38
original reports (26) 26
middle aged (25) 25
female (23) 23
adult (22) 22
male (20) 20
aged (17) 17
treatment outcome (15) 15
antibodies, monoclonal - therapeutic use (10) 10
expression (9) 9
mela7 (9) 9
metastatic melanoma (9) 9
prognosis (9) 9
kaplan-meier estimate (7) 7
neoplasm staging (7) 7
adolescent (6) 6
antibodies, monoclonal - adverse effects (6) 6
cancer (6) 6
disease-free survival (6) 6
immunotherapy - methods (6) 6
ipilimumab (6) 6
melanoma - immunology (6) 6
neoplasm metastasis (6) 6
skin neoplasms - pathology (6) 6
young adult (6) 6
aged, 80 and over (5) 5
antibody (5) 5
cancer vaccines - administration & dosage (5) 5
carcinoma (5) 5
child (5) 5
immunotherapy (5) 5
lymphocytes, tumor-infiltrating - immunology (5) 5
melanoma - drug therapy (5) 5
melanoma - therapy (5) 5
neoplasms - drug therapy (5) 5
neoplasms - immunology (5) 5
nmel (5) 5
review (5) 5
survival rate (5) 5
t-cells (5) 5
t-lymphocytes - immunology (5) 5
therapy (5) 5
time factors (5) 5
antineoplastic agents - therapeutic use (4) 4
blockade (4) 4
bone1 (4) 4
cancer vaccines - adverse effects (4) 4
cd4-positive t-lymphocytes - immunology (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
child, preschool (4) 4
colony-stimulating factor (4) 4
combined modality therapy (4) 4
diagnosis in oncology (4) 4
disease progression (4) 4
dose-response relationship, drug (4) 4
drug administration schedule (4) 4
efficacy (4) 4
lung neoplasms - drug therapy (4) 4
nivolumab (4) 4
regulatory t-cells (4) 4
risk assessment (4) 4
skin neoplasms - immunology (4) 4
to2 (4) 4
to21 (4) 4
antigen (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
antitumor immunity (3) 3
antitumor-activity (3) 3
bc8 (3) 3
bios4 (3) 3
cancer vaccines - immunology (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
cyclophosphamide - administration & dosage (3) 3
guidelines (3) 3
hema16 (3) 3
high-risk neuroblastoma (3) 3
immunohistochemistry (3) 3
immunotherapy, adoptive (3) 3
infant (3) 3
leukemia (3) 3
lung neoplasms - pathology (3) 3
lymphatic metastasis (3) 3
lymphocytes, tumor-infiltrating - pathology (3) 3
lymphoma, b-cell - immunology (3) 3
maximum tolerated dose (3) 3
melanoma - mortality (3) 3
melanoma - pathology (3) 3
melanoma - secondary (3) 3
pedi10 (3) 3
phase-ii trial (3) 3
proportional hazards models (3) 3
receptor (3) 3
remission induction (3) 3
resistant prostate-cancer (3) 3
review articles (3) 3
risk factors (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1020 - 1030
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 17, pp. 2205 - 2218
For almost four decades, my work has focused on one challenge: improving the delivery and efficacy of anticancer therapeutics. Working on the hypothesis that... 
INTERSTITIAL FLUID PRESSURE | VASCULAR NORMALIZATION | ANTIANGIOGENIC THERAPY | ONCOLOGY | PHASE-I TRIAL | NITRIC-OXIDE | FACTOR RECEPTOR-2 BLOCKADE | BLOOD-FLOW | ANTI-VEGF THERAPY | LYMPHATIC METASTASIS | ENDOTHELIAL GROWTH-FACTOR | Animals | Humans | Tumor Microenvironment | Neoplasms - blood supply | Molecular Medicine | Neoplasms - pathology | Neoplasms - drug therapy | Special | To6 | To5 | To7 | To2 | To1
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2015, Volume 33, Issue 6, pp. 540 - 549
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. 1688 - 1696
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 29, pp. 3293 - 3304
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 12, pp. 1325 - 1333
Journal Article